Cargando…

(18)F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma

BACKGROUND: Immune checkpoint blockade such as ipilimumab and anti-PD1 monoclonal antibodies have significantly improved survival in advanced melanoma. Biomarkers are urgently needed as a majority of patients do not respond, despite treatment-related toxicities. We analysed pre-treatment (18)F-fluor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Annie, Callahan, Jason, Keyaerts, Marleen, Neyns, Bart, Mangana, Johanna, Aberle, Susanne, Herschtal, Alan, Fullerton, Sonia, Milne, Donna, Iravani, Amir, McArthur, Grant A., Hicks, Rodney J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227105/ https://www.ncbi.nlm.nih.gov/pubmed/32408884 http://dx.doi.org/10.1186/s40644-020-00313-2

Ejemplares similares

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome
por: Vermeulen, Sim, et al.
Publicado: (2021)

Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [(18)F]FDG PET/CT Imaging and Clinical Features
por: Dirks, Ine, et al.
Publicado: (2023)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma
por: Weppler, Alison M, et al.
Publicado: (2020)

Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT
por: Pattison, David A., et al.
Publicado: (2019)

Overview of early response assessment in lymphoma with FDG-PET
por: MacManus, Michael P, et al.
Publicado: (2007)

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
por: Hofman, Michael S, et al.
Publicado: (2011)

The role of (18)F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
por: Hung, Te-Jui, et al.
Publicado: (2019)

Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia
por: Pijl, Jordy P., et al.
Publicado: (2020)

FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
por: McLean, Luke S., et al.
Publicado: (2021)

Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
por: Thielemans, Kris, et al.
Publicado: (2014)

PET/CT variants and pitfalls in malignant melanoma
por: Aide, Nicolas, et al.
Publicado: (2022)

Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports
por: Wilgenhof, Sofie, et al.
Publicado: (2012)

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
por: Bhave, Prachi, et al.
Publicado: (2022)

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
por: Quak, Elske, et al.
Publicado: (2015)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Sclerosing angiomatoid nodular transformation (SANT) of the spleen: a case report with FDG-PET findings and literature review
por: Imamura, Yumi, et al.
Publicado: (2016)

Intra-patient comparison of physiologic (68)Ga-PSMA-11 and (18)F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay
por: Osman, Medhat M., et al.
Publicado: (2021)

Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

The clinical significance and management of lesion motion due to respiration during PET/CT scanning
por: Callahan, Jason, et al.
Publicado: (2011)

PET tracer development—a tale of mice and men
por: Hicks, Rodney J, et al.
Publicado: (2006)

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
por: De Keersmaecker, Brenda, et al.
Publicado: (2020)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

Splenosis Mimicking Peritoneal Seeding of Advanced Colon Cancer Can Be Identified by Spleen SPECT/CT and FDG PET/CT
por: Lee, Ji Young, et al.
Publicado: (2021)

A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules
por: Callahan, Jason, et al.
Publicado: (2014)

The utility of (18) F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification
por: Cochet, Alexandre, et al.
Publicado: (2014)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients
por: Du Four, Stephanie, et al.
Publicado: (2014)

Ipilimumab
Publicado: (2012)

(68)Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
por: Iravani, Amir, et al.
Publicado: (2017)

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
por: Wolchok, Jedd D., et al.
Publicado: (2022)

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab
por: Rogiers, Anne, et al.
Publicado: (2020)

Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab
por: Minor, David R., et al.
Publicado: (2015)

A Case of Rupture of Spleen
por: Milne, Charles
Publicado: (1910)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_et8fsa5rum0fbtt43dk9aaukok